Chuck Grassley actually said...

"Many taxpayers accept complexity that favors them."

"I believe it is our duty to understand how the pharmaceutical supply chain is working, and what we can do to improve it."

"The current drug price system is so opaque that it is easy to see why there are many questions about PBM motives and practices."

"In the Grassley-Wyden 2-year investigation into insulin price-gouging, we found that that PBM scheme encourages drug makers to spike the drug list price."